Abstract
Restenosis following coronary stenting has long been attributed to neointimal proliferation, thrombosis, and negative remodeling. More recently, the important role of inflammation in vascular healing has also been increasingly well understood. From animal models and from clinical experience, we know that endothelial injury, platelet and leukocyte interactions, and subcellular chemoattractant and inflammatory mediators are pivotal in the development of the inflammatory response following stent implantation. By examining the specific mechanisms governing the inflammatory response to percutaneous coronary intervention, we may gain insight into potential therapeutic targets and strategies to prevent restenosis in clinical practice.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Grunzig AR, Senning A, Siegenthaler WE: Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979, 301:61–68.
Mintz GS, Popma JJ, Pichard AD, et al.: Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996, 94:35–43.
Post MJ, Borst C, Kuntz RE: The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994, 89:2816–2821.
Ross R: Atherosclerosis—an inflammatory disease. N Engl J Med 1999, 340:115–126.
Libby P, Ridker P, Maseri A: Inflammation and atherosclerosis. Circulation 2002, 105:1135–1143.
Cybulsky MI, Gimbrone MA: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788–791.
Dong ZM, Chapman SM, Brown AA, et al.: The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 1998, 102:145–152.
Cybulsky MI, Iiyama K, Li H, et al.: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001, 107:1255–1262.
Libby P: Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365–372.
Geng YJ, Libby P: Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995, 147:251–266.
Amento E, Ehsani N, Palmer H, et al.: Cytokines positively and negatively regulate intersitial collagen gene expression in human vascular smooth muscle cells. Arteriosclerosis 1991, 11:223.
Libby P, Simon DI: Inflammation and thrombosis: the clot thickens. Circulation 2001, 103:1718–1720.
Mach F, Schonbeck U, Bonnefoy JY, et al.: Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation 1997, 96:396–399.
Henn V, Slupsky JR, Grafe M, et al.: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998, 391:591–594.
Libby P, Schwartz D, Brogi E, et al.: A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992, 86:III47-III52.
Welt FG, Rogers C: Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002, 22:1769–1776.
Simon DI, Chen Z, Seifert P, et al.: Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest 2000, 105:293–300.
Rogers C, Edelman ER, Simon DI: A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci U S A 1998, 95:10134–10139.
Tanguay JF, Geoffroy P, Sirois MG, et al.: Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb Haemost 2004, 91:1186–1193.
Tanaka H, Sukhova GK, Swanson SJ, et al.: Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury. Circulation 1993, 88:1788–1803.
Rogers C, Welt FG, Karnovsky MJ, Edleman ER: Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996, 16:1312–1318.
Welt FG, Edelman ER, Simon DI, Rogers C: Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol 2000, 20:2553–2558.
Rogers C, Edelman ER: Controlled release of heparin reduces neointimal hyperplasia in stented rabbit arteries: ramifications for local therapy. J Interv Cardiol 1992, 5:192–202.
Edelman ER, Karnovsky MJ: Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation 1994, 89:770–776.
Horvath C, Welt FG, Nedelman M, et al.: Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocyte targeted. Circ Res 2002, 90:488–494.
Gaspardone A, Crea F, Versaci F, et al.: Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998, 82:515–518.
Versaci F, Gaspardone A, Tomai F, et al.: Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000, 85:92–95, A8.
Kamijikkoku S, Murohara T, Tayama S, et al.: Acute myocardial infarction and increased soluble intercellular adhesion molecule-1: a marker of vascular inflammation and a risk of early restenosis? Am Heart J 1998, 6:231–236.
Inoue T, Hoshi K, Yaguchi I, et al.: Serum levels of circulating adhesion molecules after coronary angioplasty. Cardiology 1999, 91:236–242.
Ishiwata S, Tukada T, Nakanishi S, et al.: Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J 1997, 133:387–392.
Tsakiris DA, Tschopl M, Jager K, et al.: Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999, 142:193–200.
Pietersma A, Koffard M, de Wit LE, et al.: Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995, 91:1320–1325.
Cipollone F, Marini M, Fazia M, et al.: Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001, 21:327–334.
Neumann FJ, Ott I, Gawaz M, et al.: Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 1996, 27:819–824.
Mickelson JK, Lakkis NM, Villarreal-Levy G, et al.: Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 1996, 28:345–353.
Koch W, Bottiger C, Mehilli J, et al.: Association of a CD18 gene polymorphism with reduced risk of restenosis after coronary stenting. Am J Cardiol 2001, 88:1120–1124.
Moreno PR, Bernardi VH, Lopez-Cuellar J, et al.: Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996, 94:3098–3102.
Farb A, Sangiorgi G, Carter AJ, et al.: Pathology of acute and chronic coronary stenting in humans. Circulation 1999, 99:44–52.
Sy MS, Schneeberger E, McCluskey R, et al.: Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity. Cell Immunol 1983, 82:23–32.
Clowes AW, Clowes MM: Inhibition of smooth muscle cell proliferation by heparin molecules. Transplant Proc 1989, 21:3700–3701.
Simon DI, Xu H, Ortlepp S, et al.: 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol 1997, 17:528–535.
Plescia J, Conte MS, VanMeter G, et al.: Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence. J Biol Chem 1998, 273:20372–20377.
Altieri DC, Edgington TS: A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol 1988, 141:2656–2660.
Cote G, Tardif JC, Lesperance J, et al.: Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and protocol study group. Circulation 1999, 99:30–35.
Holmes DR Jr, Savage MP, LaBlanche JM, et al.: Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 2000, 106:1243–1250.
Suzuki T, Kopia G, Hayashi S, et al.: Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation, 2001, 104:1188–1193.
Drachman DE, Edelman ER, Seifert P, et al.: Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol 2000, 36:2325–2332.
Straubinger R: Biopharmaceuticals of paclitaxel (Taxol): formulation, activity, and pharmacokinetics. In Taxol: Science and Applications. Edited by Suffness M. Boca Raton, FL: CRC Press; 1995:237.
Virmani R, Guagliumi G, Farb A, et al.: Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004, 109:701–705.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Drachman, D.E., Simon, D.I. Inflammation as a mechanism and therapeutic target for in-stent restenosis. Curr Atheroscler Rep 7, 44–49 (2005). https://doi.org/10.1007/s11883-005-0074-5
Issue Date:
DOI: https://doi.org/10.1007/s11883-005-0074-5